Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleDrug Discovery and Translational Medicine

Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy

Ismayil Ahmet, Hyun-Jin Tae, Michael Brines, Anthony Cerami, Edward G. Lakatta and Mark I. Talan
Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 446-456; DOI: https://doi.org/10.1124/jpet.113.202945
Ismayil Ahmet
Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyun-Jin Tae
Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Brines
Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Cerami
Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward G. Lakatta
Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark I. Talan
Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 345 no. 3 446-456
DOI 
https://doi.org/10.1124/jpet.113.202945
PubMed 
23584743

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received January 4, 2013
  • Accepted April 10, 2013
  • Published online May 16, 2013.

Article Versions

  • Earlier version (April 12, 2013 - 07:12).
  • You are viewing the most recent version of this article.
Copyright & Usage 
U.S. Government work not protected by U.S. copyright

Author Information

  1. Ismayil Ahmet,
  2. Hyun-Jin Tae,
  3. Michael Brines,
  4. Anthony Cerami,
  5. Edward G. Lakatta, and
  6. Mark I. Talan
  1. Laboratory of Cardiovascular Sciences, National Institute on Aging/National Institutes of Health, Baltimore, Maryland (I.A., H.-J.T., E.G.L., M.I.T.); and Araim Pharmaceuticals, Ossining, New York (M.B., A.C.)
  1. Address correspondence to:
    Mark I. Talan, National Institute on Aging, 5600 Nathan Shock Drive, Baltimore, MD 21224-6825. E-mail: talanm{at}grc.nia.nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: April 2013 to January 2021

AbstractFullPdf
Apr 2013185063
May 20134822479
Jun 20132581527
Jul 2013651318
Aug 20134566
Sep 20137024
Oct 20133245
Nov 20131344
Dec 20132434
Jan 20141946
Feb 20143821
Mar 20142469
Apr 201427212
May 201419721
Jun 2014171230
Jul 2014251015
Aug 20143714
Sep 201417932
Oct 201410619
Nov 201414420
Dec 201451110
Jan 2015111112
Feb 2015889
Mar 201510126
Apr 20156106
May 2015856
Jun 20152112
Jul 2015131110
Aug 2015982
Sep 201512811
Oct 2015898
Nov 20151436
Dec 20151244
Jan 201616119
Feb 20161625
Mar 201630411
Apr 2016562
May 2016875
Jun 20168614
Jul 201610923
Aug 201616920
Sep 201610512
Oct 201621614
Nov 20161152
Dec 201602012
Jan 20171209
Feb 20173183
Mar 20171174
Apr 20170186
May 20171124
Jun 20170115
Jul 20171133
Aug 20170149
Sep 20170112
Oct 20170112
Nov 20171107
Dec 20171188
Jan 20181142
Feb 201801411
Mar 20180184
Apr 20182186
May 20180204
Jun 20180232
Jul 20183181
Aug 20180153
Sep 20180235
Oct 201801110
Nov 20180123
Dec 20181111
Jan 2019710
Feb 20191122
Mar 20191001
Apr 20191100
May 2019711
Jun 20191004
Jul 20191100
Aug 2019909
Sep 20191706
Oct 20191323
Nov 20191700
Dec 20192203
Jan 20201921
Feb 2020800
Mar 20202026
Apr 2020522
May 2020201
Jun 20201111
Jul 20201203
Aug 2020611
Sep 2020202
Oct 20202000
Nov 20202314
Dec 2020621
Jan 2021605

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 345 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 345, Issue 3
1 Jun 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleDrug Discovery and Translational Medicine

A Novel Small-Peptide Treatment in a Rat Model of CHF

Ismayil Ahmet, Hyun-Jin Tae, Michael Brines, Anthony Cerami, Edward G. Lakatta and Mark I. Talan
Journal of Pharmacology and Experimental Therapeutics June 1, 2013, 345 (3) 446-456; DOI: https://doi.org/10.1124/jpet.113.202945

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleDrug Discovery and Translational Medicine

A Novel Small-Peptide Treatment in a Rat Model of CHF

Ismayil Ahmet, Hyun-Jin Tae, Michael Brines, Anthony Cerami, Edward G. Lakatta and Mark I. Talan
Journal of Pharmacology and Experimental Therapeutics June 1, 2013, 345 (3) 446-456; DOI: https://doi.org/10.1124/jpet.113.202945
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cx43 Activity and Modulation in the Myometrium
  • IKCa channels in muscle hypertrophy
  • Cellular impedance assay to predict human TRPV4 inhibition
Show more Drug Discovery and Translational Medicine

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics